Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT and Keytruda in mCRPC
NCT04116775Phase 2Unknown
- Start
- Oct 2019
- Primary completion
- Oct 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation capsules in metastatic castration-resistant prostate cancer (mCRPC). Status: unknown.
02
Drugs
Fecal Microbiota Transplantation capsules
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT04116775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04116775.